Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.75 USD | -6.16% | -2.50% | +58.79% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 369M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 60.5 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 61 x |
P/E ratio 2024 * |
-3.59
x | P/E ratio 2025 * |
-3.53
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.91% |
Latest transcript on Solid Biosciences Inc.
1 day | -6.16% | ||
1 week | -2.50% | ||
Current month | +9.92% | ||
1 month | -5.98% | ||
3 months | +24.20% | ||
6 months | +351.39% | ||
Current year | +58.79% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 9.75 | -6.16% | 163,043 |
24-05-10 | 10.39 | +0.48% | 175,420 |
24-05-09 | 10.34 | +0.88% | 67,663 |
24-05-08 | 10.25 | -1.63% | 106,454 |
24-05-07 | 10.42 | +4.20% | 174,822 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.79% | 369M | |
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- SLDB Stock